Document is current
Any future updates will be listed below
-
Authors
Barrios, Joshua P. https://orcid.org/0000-0003-1618-6244
Ansari, Minhaj U.
Olgin, Jeffrey E.
Abreau, Sean
Delfrate, Jacques https://orcid.org/0009-0001-0466-1354
Langlais, Elodie L. https://orcid.org/0009-0007-3019-4829
Avram, Robert https://orcid.org/0000-0002-8490-0270
Tison, Geoffrey H. https://orcid.org/0000-0002-0310-3326
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K23HL135274)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (DP2HL174046)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R56HL161475)
- License Information
-
More Information
Article History
Received: 25 June 2024
Accepted: 2 February 2026
First Online: 17 March 2026
Competing interests
: G.H.T. has previously received research grants from Janssen Pharmaceuticals and MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, and is an advisor to Prolaio Inc. and Viz.ai. S.A. was at UCSF during his contribution to this work; the information and views herein are solely S.A.’s and do not represent his current employer (Point72). The other authors declare no competing interests.
